ADVFN US – Market Content Editor
-
Crude Oil Slides as Trade Tensions and Oversupply Worries Weigh on Market
Oil prices slipped at the start of the week, pressured by renewed concerns over excess supply and slowing global demand as U.S.-China trade tensions intensified. By 00:32 GMT, Brent crude futures were down 24 cents, or 0.4%, at $61.05 per barrel, while U.S. West Texas Intermediate futures fell 21 cents, or 0.4%, to $57.33, reversing…
-
JPMorgan Sees U.S. Earnings Outperforming Eurozone in Q3, Cyclicals Could Turn the Corner
The upcoming earnings season is expected to once again underscore the widening performance gap between U.S. and eurozone corporates, according to strategists at JPMorgan Chase & Co.. Consensus forecasts point to a 6% year-on-year increase in S&P 500 earnings, compared with a 1% decline for the STOXX Europe 600. Unlike the typical pre-earnings downgrades, analyst…
-
Earnings Season Becomes Crucial Test for AI-Driven Market Optimism, Barclays Warns
The third-quarter earnings season has arrived at a critical juncture for financial markets, shifting the focus from broad macroeconomic themes to AI-fueled optimism and company-level performance. According to strategists at Barclays, “earnings are set to take center stage, potentially pivotal for sustaining the rally,” making this a defining “show-me moment” for the AI-driven market narrative.…
-
Gold could reach $5,000 an ounce next year, say HSBC analysts
HSBC analysts have lifted their price outlook for gold, projecting the precious metal could climb to $5,000 per ounce in 2026 as uncertainty across global markets deepens. In a note to clients, the brokerage said that the ongoing surge in gold prices will likely stretch into the first half of 2026, supported by its safe-haven…
-
Citi warns of more turbulence ahead for equity bull market
Strategists at Citigroup, led by Beata Manthey, cautioned that the ongoing equity bull market may be heading into a choppier, more volatile stretch. They pointed to renewed tensions between the U.S. and China as a major source of uncertainty, emphasizing that “stakes are high and the path to resolution appears complex.” With earnings season picking…
-
U.S. Stocks Move Back To The Upside As Bank Credit Concerns Quickly Fade
After showing a lack of direction early in the session, stocks moved mostly higher over the course of the trading day on Friday. The major averages all moved to the upside, regaining ground following the downturn seen in the previous session. The major averages finished the day off their highs of the session but still…
-
Freeport-McMoRan to benefit from stronger copper and gold prices
HSBC upgraded Freeport-McMoRan (NYSE:FCX) to Buy from Hold and raised its price target to $50 from $43, citing a supportive environment for copper and gold prices that should bolster earnings, even as the miner faces operational setbacks at its flagship Grasberg mine in Indonesia. Copper has outperformed other base and bulk metals this year amid…
-
Taoping Inc. stock falls after announcing non-binding acquisition LOI
Taoping Inc. (NASDAQ:TAOP) shares dropped 8.4% in premarket trading on Friday after the company revealed it had signed a non-binding Letter of Intent (LOI) to acquire Alphalion Holding Limited. Under the proposed transaction, Taoping would acquire 100% of Alphalion’s equity. The deal remains contingent on due diligence, negotiation of a definitive agreement, and standard closing…
-
Protalix BioTherapeutics Inc stock plunges after CHMP rejects alternative Elfabrio dosing regimen
Protalix BioTherapeutics Inc (AMEX:PLX) shares tumbled 20.8% in premarket trading on Friday after the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a negative opinion on the company’s application to approve an alternative dosing schedule for its Fabry disease therapy Elfabrio. The CHMP rejected Protalix’s proposal for a…
-
Avita Medical Ltd stock tumbles after CEO exit and Board shake-up
Avita Medical Ltd (NASDAQ:RCEL) shares plunged 21.9% in premarket trading on Friday after the company announced a sudden leadership transition and major Board changes. The wound care therapeutics firm said Chairman Cary Vance has been appointed Interim Chief Executive Officer, replacing Jim Corbett, who is stepping down from both his CEO role and his seat…